Cardlytics, Inc. updated its guidance for the quarter ended June 30, 2022 now expecting revenue of $74.5 million to $76.5 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.94 USD | -1.97% | -16.97% | +29.64% |
Apr. 09 | Cardlytics, Inc. Appoints Liane Hornsey to Its Board of Directors | CI |
Apr. 09 | Needham Raises Cardlytics' Price Target to $17 From $15, Maintains Buy Rating | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.64% | 575M | |
+7.52% | 3,004B | |
+0.93% | 79.28B | |
+4.97% | 77.94B | |
-13.76% | 53.9B | |
-18.60% | 50.22B | |
+23.06% | 46.76B | |
+12.30% | 39.49B | |
+39.01% | 31.91B | |
-12.62% | 23.99B |
- Stock Market
- Equities
- CDLX Stock
- News Cardlytics, Inc.
- Cardlytics Provides Revenue Guidance for the Quarter Ended June 30, 2022